JFBR Jeffs Brands Ltd

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

Form 6-K

 

 

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934

 

For the month of November 2022 (Report No. 3)

 

Commission file number: 001-41482

 

 

Jeffs’ Brands Ltd

(Translation of registrant’s name into English)

 

 

3 Hanechoshet St.
Tel Aviv, Israel 6971068
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒            Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____

 

 

 

CONTENTS

 

On November 15, 2022, Jeffs’ Brands Ltd issued a press release titled “Jeffs’ Brands Enters Into Letter of Intent with a Pharmaceutical Company to Establish a Joint Venture to Develop and Market a New Product Line,” a copy of which is furnished as Exhibit 99.1 with this report of foreign private issuer on Form 6-K.

 

EXHIBIT INDEX

 

Exhibit No.
99.1		Press release issued by Jeffs’ Brands Ltd dated November 15, 2022, titled “Jeffs’ Brands Enters Into Letter of Intent with a Pharmaceutical Company to Establish a Joint Venture to Develop and Market a New Product Line.”

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Jeffs’ Brands Ltd
Date: November 16, 2022	By:	/s/ Viki Hakmon
		Viki Hakmon
		Chief Executive Officer

 

 

2